Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-19

Clinical Trial Update: Famvir for Treatment of Hearing in Unilateral Meniere's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on Famvir for treatment of hearing in unilateral Meniere's Disease; the study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famvir (famciclovir)

Snippet

Sponsor: House Research Institute | Conditions: Meniere's Disease | Phase 3 | Status: TERMINATED | Results posted: 2021-04-19